|Bid||0.00 x 900|
|Ask||0.00 x 900|
|Day's Range||171.33 - 173.62|
|52 Week Range||93.10 - 179.01|
|Beta (5Y Monthly)||0.71|
|PE Ratio (TTM)||14.07|
|Earnings Date||Jul 26, 2021 - Jul 30, 2021|
|Forward Dividend & Yield||3.20 (1.87%)|
|Ex-Dividend Date||Mar 18, 2021|
|1y Target Est||184.86|
ZURICH, May 4, 2021 The Chubb Charitable Foundation today announced that it is committing $500,000 to COVID-19 relief efforts in India, which is facing a catastrophic humanitarian crisis from a record surge in coronavirus infections. The support will go to the American India Foundation (AIF) to provide emergency medical equipment and supplies.
New data from Chubb and the National Center for the Middle Market (NCMM), housed at The Ohio State University Fisher College of Business, reveals that the worst of the pandemic's economic impact might be in the rearview mirror for middle market companies.
Chubb and Marsh today announced a collaboration with the World Health Organization (WHO) and Gavi, the Vaccine Alliance (Gavi), that has secured insurance coverage for a Program that will offer eligible individuals in 92 lower-income countries and economies a fast, fair and transparent process to receive compensation for rare but serious adverse events associated with vaccines distributed through COVAX up to June 30, 2022. The COVAX No-fault Compensation Program is the first and only vaccine injury compensation mechanism operating on an international scale.